CLINICAL_TRIALS
trial_result
· 2020-09-18
Clinical Trial Update: A Study To Compare The Effectiveness Of Tofacitinib 11 Mg Once A Day To Tofacitinib 5 Mg Twice A Day
Summary
A completed clinical trial comparing once-daily 11 mg to twice-daily 5 mg tofacitinib in rheumatoid arthritis has posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Arthritis Rheumatoid | Status: COMPLETED | Results posted: 2020-09-18